FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1999215389> ?p ?o ?g. }

• W1999215389 endingPage "598" @default.
• W1999215389 startingPage "592" @default.
• W1999215389 abstract "To analyze the expression of hypoxia-inducible factors (hypoxia-inducible factor 1A and hypoxia-inducible factor 2A) and aldehyde dehydrogenase proteins in patients with locally advanced breast carcinoma who were subjected to neoadjuvant chemotherapy.We included 90 patients with histologically confirmed stage II and III breast carcinoma who were treated with neoadjuvant chemotherapy between 2000 and 2005. Immunohistochemistry for aldehyde dehydrogenase, hypoxia-inducible factor 1A, and hypoxia-inducible factor 2A was performed before and after neoadjuvant chemotherapy. We analyzed the influence of clinical and pathological features on clinical and pathological response, disease-free survival, and overall survival.An objective clinical response to neoadjuvant chemotherapy was observed in 80% of patients, with 12% showing a complete pathological response. Among all clinical and pathological parameters, only the expression of hypoxia-inducible factor 1A was associated with a pathological response. A positive association was found between expression of aldehyde dehydrogenase and that of hypoxia-inducible factor 1A before and after chemotherapy. Aldehyde dehydrogenase expression was associated with expression of hypoxia inducible-factor 2A in tumors after neoadjuvant treatment. In a univariate analysis, prognosis was influenced by age, pathological response, metastasis to axillary lymph nodes after neoadjuvant chemotherapy, overexpression of hypoxia-inducible factor 2, and the presence of aldehyde dehydrogenase-positive cells within the primary tumor after neoadjuvant chemotherapy. In a multivariate analysis, only age and the presence of aldehyde dehydrogenase-positive cells after chemotherapy were associated with reduced overall survival.The presence of aldehyde dehydrogenase-positive cells within the residual tumor after neoadjuvant chemotherapy is associated with an increase in the expression of hypoxia-inducible factor 2A and with poor prognosis in patients with locally advanced breast cancer." @default.
• W1999215389 created "2016-06-24" @default.
• W1999215389 creator A5006084752 @default.
• W1999215389 creator A5008447927 @default.
• W1999215389 creator A5038400415 @default.
• W1999215389 creator A5049024133 @default.
• W1999215389 creator A5082127041 @default.
• W1999215389 creator A5085876480 @default.
• W1999215389 creator A5090278499 @default.
• W1999215389 date "2013-05-01" @default.
• W1999215389 modified "2023-10-04" @default.
• W1999215389 title "Expression of aldehyde dehydrogenase after neoadjuvant chemotherapy is associated with expression of hypoxia-inducible factors 1 and 2 alpha and predicts prognosis in locally advanced breast cancer" @default.
• W1999215389 cites W1568076150 @default.
• W1999215389 cites W1593442063 @default.
• W1999215389 cites W1955397179 @default.
• W1999215389 cites W1976248697 @default.
• W1999215389 cites W1982553615 @default.
• W1999215389 cites W1983486852 @default.
• W1999215389 cites W2001544973 @default.
• W1999215389 cites W2005085809 @default.
• W1999215389 cites W2017654880 @default.
• W1999215389 cites W2023316892 @default.
• W1999215389 cites W2023427658 @default.
• W1999215389 cites W2025021524 @default.
• W1999215389 cites W2034890051 @default.
• W1999215389 cites W2035214634 @default.
• W1999215389 cites W2037568638 @default.
• W1999215389 cites W2039075677 @default.
• W1999215389 cites W2042198997 @default.
• W1999215389 cites W2043433914 @default.
• W1999215389 cites W2044149912 @default.
• W1999215389 cites W2044905529 @default.
• W1999215389 cites W2051588629 @default.
• W1999215389 cites W2075054245 @default.
• W1999215389 cites W2090982381 @default.
• W1999215389 cites W2105504936 @default.
• W1999215389 cites W2107708906 @default.
• W1999215389 cites W2112443004 @default.
• W1999215389 cites W2115792588 @default.
• W1999215389 cites W2117462751 @default.
• W1999215389 cites W2127965231 @default.
• W1999215389 cites W2129990146 @default.
• W1999215389 cites W2131994307 @default.
• W1999215389 cites W2134361367 @default.
• W1999215389 cites W2139510434 @default.
• W1999215389 cites W2140551998 @default.
• W1999215389 cites W2151948621 @default.
• W1999215389 cites W2155779354 @default.
• W1999215389 cites W2158627893 @default.
• W1999215389 cites W2159640574 @default.
• W1999215389 cites W2162272563 @default.
• W1999215389 cites W2203102867 @default.
• W1999215389 cites W2917423152 @default.
• W1999215389 cites W4241726394 @default.
• W1999215389 doi "https://doi.org/10.6061/clinics/2013(05)03" @default.
• W1999215389 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3654340" @default.
• W1999215389 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23778413" @default.
• W1999215389 hasPublicationYear "2013" @default.
• W1999215389 type Work @default.
• W1999215389 sameAs 1999215389 @default.
• W1999215389 citedByCount "11" @default.
• W1999215389 countsByYear W19992153892014 @default.
• W1999215389 countsByYear W19992153892015 @default.
• W1999215389 countsByYear W19992153892016 @default.
• W1999215389 countsByYear W19992153892018 @default.
• W1999215389 countsByYear W19992153892020 @default.
• W1999215389 countsByYear W19992153892022 @default.
• W1999215389 crossrefType "journal-article" @default.
• W1999215389 hasAuthorship W1999215389A5006084752 @default.
• W1999215389 hasAuthorship W1999215389A5008447927 @default.
• W1999215389 hasAuthorship W1999215389A5038400415 @default.
• W1999215389 hasAuthorship W1999215389A5049024133 @default.
• W1999215389 hasAuthorship W1999215389A5082127041 @default.
• W1999215389 hasAuthorship W1999215389A5085876480 @default.
• W1999215389 hasAuthorship W1999215389A5090278499 @default.
• W1999215389 hasBestOaLocation W19992153891 @default.
• W1999215389 hasConcept C104317684 @default.
• W1999215389 hasConcept C121608353 @default.
• W1999215389 hasConcept C126322002 @default.
• W1999215389 hasConcept C142724271 @default.
• W1999215389 hasConcept C143998085 @default.
• W1999215389 hasConcept C160450060 @default.
• W1999215389 hasConcept C178790620 @default.
• W1999215389 hasConcept C181199279 @default.
• W1999215389 hasConcept C185592680 @default.
• W1999215389 hasConcept C204232928 @default.
• W1999215389 hasConcept C207886595 @default.
• W1999215389 hasConcept C25747580 @default.
• W1999215389 hasConcept C2776694085 @default.
• W1999215389 hasConcept C2778292576 @default.
• W1999215389 hasConcept C502942594 @default.
• W1999215389 hasConcept C530470458 @default.
• W1999215389 hasConcept C540031477 @default.
• W1999215389 hasConcept C55493867 @default.
• W1999215389 hasConcept C71924100 @default.
• W1999215389 hasConcept C7836513 @default.
• W1999215389 hasConcept C86803240 @default.
• W1999215389 hasConceptScore W1999215389C104317684 @default.

• next